PCYT2 and metabolic syndrome: Even the disruption of one allele of Pcyt2 in the Pcyt2+/−mouse has major physiological effects as these animals develop insulin resistance, obesity, dyslipidaemia and liver steatosis, the hallmarks of metabolic syndrome.